Scott A. Kendrick - Concepedia

Concepedia

Author

Scott A. Kendrick

Terasaki Foundation

Also Known As

S. A. Kendrick, S.A. Kendrick, Scott A Kendrick, Scott A. Kendrick, Scott Kendrick

17

Publications

1.1K

Citations

11

H-Index

30

Concepts

All Affiliations

Terasaki Foundation East Carolina University Vidant Medical Center

SA

About

Scott A. Kendrick is an author at Terasaki Foundation specializing in chronic kidney disease, medicine, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	131
2	Health Sciences	1	1	119
3	Allergy	1	1	12
4	Hepatology	1	1	119
5	Immunology	1	1	12

Scott A. Kendrick

×

11

Publications

1.1K

Citations

11

H-Index

	Year	Citations
Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts Matthew J. Everly, Lorita M. Rebellato, Carl E. Haisch, Transplantation	2013	368
Higher Risk of Kidney Graft Failure in the Presence of Anti-Angiotensin II Type-1 Receptor Antibodies Masatake Taniguchi, Lorita M. Rebellato, Junchao Cai, American Journal of Transplantation	2013	201
The Role of Immunoglobulin-G Subclasses and C1q in De Novo HLA-DQ Donor-Specific Antibody Kidney Transplantation Outcomes Maria Cecília S. Freitas, Lorita M. Rebellato, Miyuki Ozawa, Transplantation	2013	176
Hemodialysis Acutely Improves Hepatic CYP3A4 Metabolic Activity Thomas D. Nolin, K. K. Appiah, Scott A. Kendrick, Journal of the American Society of Nephrology Dialysis TherapyRedox BiologyRenal FunctionBioanalysisToxicology	2006	119
Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: Data from a single US institution Paula I. Burgos, Elizabeth L. Perkins, Guillermo Pons‐Estel, Arthritis & Rheumatism	2009	82
Impact of IgM and IgG3 Anti-HLA Alloantibodies in Primary Renal Allograft Recipients Matthew J. Everly, Lorita M. Rebellato, Carl E. Haisch, Transplantation	2014	77
Onset and progression of <i>de novo</i> donor‐specific anti‐human leukocyte antigen antibodies after <scp>BK</scp> polyomavirus and preemptive immunosuppression reduction Georg Dieplinger, Matthew J. Everly, Kimberly P. Briley, Transplant Infectious Disease	2015	36
Trends and Characteristics in Early Glomerular Filtration Rate Decline After Posttransplantation Alloantibody Appearance Pingping Wu, Matthew J. Everly, Lorita M. Rebellato, Transplantation	2013	15
Racial differences in incident <i>de novo</i> donor-specific anti-HLA antibody among primary renal allograft recipients: results from a single center cohort study Matthew J. Everly, Kimberly P. Briley, Carl E. Haisch, Transplant International	2017	15
Changes in Successive Measures of De Novo Donor-Specific Anti–Human Leukocyte Antigen Antibodies Intensity and The Development of Allograft Dysfunction Georg Dieplinger, Matthew J. Everly, Lorita M. Rebellato, Transplantation	2014	14

Page 1